SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-22-003885
Filing Date
2022-03-18
Accepted
2022-03-18 09:51:19
Documents
78
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tmb-20211231x10k.htm   iXBRL 10-K 1662423
2 EX-23.1 tmb-20211231xex23d1.htm EX-23.1 3415
3 EX-31.1 tmb-20211231xex31d1.htm EX-31.1 14968
4 EX-31.2 tmb-20211231xex31d2.htm EX-31.2 14725
5 EX-32 tmb-20211231xex32.htm EX-32 10325
6 GRAPHIC tmb-20211231x10k001.jpg GRAPHIC 39088
7 GRAPHIC tmb-20211231x10k002.jpg GRAPHIC 40369
8 GRAPHIC tmb-20211231x10k003.jpg GRAPHIC 24966
9 GRAPHIC tmb-20211231x10k004.jpg GRAPHIC 19108
10 GRAPHIC tmb-20211231x10k005.jpg GRAPHIC 8366
11 GRAPHIC tmb-20211231x10k006.jpg GRAPHIC 7649
12 GRAPHIC tmb-20211231x10k007.jpg GRAPHIC 20594
13 GRAPHIC tmb-20211231x10k009.jpg GRAPHIC 39668
14 GRAPHIC tmb-20211231x10k010.jpg GRAPHIC 27348
15 GRAPHIC tmb-20211231x10k011.jpg GRAPHIC 36368
16 GRAPHIC tmb-20211231x10k012.jpg GRAPHIC 31936
17 GRAPHIC tmb-20211231x10k013.jpg GRAPHIC 14162
  Complete submission text file 0001558370-22-003885.txt   6352447

Data Files

Seq Description Document Type Size
18 EX-101.SCH tmb-20211231.xsd EX-101.SCH 44220
19 EX-101.CAL tmb-20211231_cal.xml EX-101.CAL 38440
20 EX-101.DEF tmb-20211231_def.xml EX-101.DEF 166844
21 EX-101.LAB tmb-20211231_lab.xml EX-101.LAB 392662
22 EX-101.PRE tmb-20211231_pre.xml EX-101.PRE 304802
72 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20211231x10k_htm.xml XML 579141
Mailing Address 44 MILTON AVENUE ALPHARETTA GA 30009
Business Address 44 MILTON AVENUE ALPHARETTA GA 30009 8666208655
Virios Therapeutics, Inc. (Filer) CIK: 0001818844 (see all company filings)

IRS No.: 854314201 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39811 | Film No.: 22751321
SIC: 2834 Pharmaceutical Preparations